Companies / BOC Sciences / Tezepelumab
BOC Sciences

Tezepelumab | BOC Sciences

Tezepelumab is a monoclonal antibody that targets thymic stromal lymphopoietin (TSLP), a cytokine involved in the initiation and maintenance of allergic and inflammatory responses. Tezepelumab binds to TSLP and inhibits its interaction with its receptor complex, thereby blocking the downstream signaling pathways that lead to inflammation and the activation of various immune cells involved in allergic responses. It is indicated for the treatment of severe asthma. Specifically, tezepelumab is used in patients with uncontrolled asthma despite treatment with high-dose inhaled corticosteroids and other asthma controllers. It helps to reduce asthma exacerbations and improve lung function.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.